MAISi

Ennov CTMS facilitates the end-to-end management of clinical trials. The software allows sponsors to be more efficient, to make better decisions, to ensure compliance, to select investigators well, to monitor patient recruitment and to manage finances. Ennov CTMS includes comprehensive directories to manage site personnel (investigators, sub-investigators, study coordinators, pharmacists) and organizations (hospitals, competent authorities, CROs, suppliers). Ennov CTMS provides functions for tracking patients, patient visits, EDC data, activities, queries, deviations, adverse events, drug supply, monitoring visits and finances. A full complement of reports and dashboards provide total visibility into the status of each study, country, site and investigator to provide the information necessary to make the best decisions possible. - Comprehensive CTMS software - Integrated with Ennov Clinical Data Management - Clear visibility into investigational sites - Integrated workflow

AQ Platform is clinical research management software for NHS trusts, investigator sites, clinical trials units, site networks, CROs, sponsors and academic research teams. Its modules cover trial management, electronic trial and investigator site files, pharmacy and laboratory workflows, quality management, CAPA, and digital delegation of authority. Shared governed trial records and audit trails connect study operations. Connected Intelligence uses AI to flag gaps and draft next steps; a named user confirms each proposal, and customer data is not used to train models. Hosted in Microsoft Azure UK regions, the platform is designed around ICH E6(R3) and MHRA GCP inspection expectations. AQ Trials holds NHS DSPT Standards Met (2026) and Cyber Essentials certification. Phase 1 trial doctors built it; modules can be deployed individually, and it has been in daily NHS use since 2020.